Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 17;9(7):ofac298.
doi: 10.1093/ofid/ofac298. eCollection 2022 Jul.

Anatomic Site-Specific Gonorrhea and Chlamydia Testing and Incidence Among People With HIV Engaged in Care at 4 US Clinical Centers, 2014-2018

Affiliations

Anatomic Site-Specific Gonorrhea and Chlamydia Testing and Incidence Among People With HIV Engaged in Care at 4 US Clinical Centers, 2014-2018

Timothy W Menza et al. Open Forum Infect Dis. .

Abstract

Background: The incidence of Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) is increasing in the United States; however, there are limited data on anatomic site-specific GC/CT among people with HIV (PWH).

Methods: We reviewed records of all PWH in care between January 1, 2014, and November 16, 2018, at 4 sites in the CFAR Network of Integrated Clinical Systems Cohort (CNICS; n = 8455). We calculated anatomic site-specific GC/CT testing and incidence rates and used Cox proportional hazards models modified for recurrent events to examine sociodemographic and clinical predictors of GC/CT testing and incidence at urogenital, rectal, and pharyngeal sites. We also calculated site-specific number needed to test (NNT) to detect a positive GC/CT test.

Results: Of 8455 PWH, 2460 (29.1%) had at least yearly GC/CT testing at any anatomic site. The rates of urogenital, rectal, and pharyngeal GC were 1.7 (95% CI, 1.6-1.9), 3.2 (95% CI, 3.0-3.5), and 2.7 (95% CI, 2.5-2.9) infections per 100 person-years, respectively. The rates of urogenital, rectal, and pharyngeal CT were 1.9 (95% CI, 1.7-2.1), 4.3 (95% CI, 4.0-4.5), and 0.9 (95% CI, 0.8-1.0) infections per 100 person-years, respectively. PWH 16-39 years old experienced greater GC/CT rates at all anatomic sites, while men who have sex with men experienced greater rates of extragenital infections. NNTs for urogenital, rectal, and pharyngeal GC/CT were 20 (95% CI, 19-21), 5 (95% CI, 5-5), and 9 (95% CI, 8-9), respectively.

Conclusions: Many PWH are not tested annually for GC/CT, and rates of GC/CT infection, particularly rates of extragenital infections, are high. We identified groups of PWH who may benefit from increased site-specific GC/CT testing.

Keywords: chlamydia; gonorrhea; incidence; people with HIV; testing.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Workowski KA, Bachmann LH, Chan, PA, et al. . Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70:1–187. - PMC - PubMed
    1. Landovitz RJ, Gildner JL, Leibowitz AA. Sexually transmitted infection testing of HIV-positive Medicare and Medicaid enrollees falls short of guidelines. Sex Transm Dis 2018; 45:8–13. - PMC - PubMed
    1. Li J, Armon C, Palella FJ, et al. . Chlamydia and gonorrhea incidence and testing among patients in the human immunodeficiency virus outpatient study (HOPS), 2007–2017. Clin Infect Dis Off Publ Infect Dis Soc Am 2020; 71:1824–35. - PubMed
    1. Centers for Disease Control and Prevention . Sexually Transmitted Disease Surveillance, 2019. Centers for Disease Control and Prevention; 2021.
    1. Secco AA, Akselrod H, Czeresnia J, et al. . Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort. Sex Transm Infect 2020; 96:89–95. - PMC - PubMed